Kinin-dependent hypersensitivity reactions in hemodialysis: Metabolic and genetic factors
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Although the association of angiotensin I-converting enzyme inhibitors (ACEis) with a negatively charged membrane is thought to be responsible for hypersensitivity reactions (HSRs) during hemodialysis, we hypothesize that these complications are due to changes in plasma aminopeptidase P (APP) activity and genotype. To test this hypothesis, we measured plasma APP activity in 14 patients who suffered HSR (HSR+) while dialyzed with an AN69 membrane and simultaneously treated with an ACEi. APP activity was also studied in a control group (n=39) dialyzed under the same conditions, but who did not suffer any side effect (HSR-). We found significantly decreased plasma APP activity (P=0.013) in HSR+ subjects as well as altered degradation of endogenous des-Arginine(9)-bradykinin, with a significantly lower beta value (P<0.001). The same analytical approach was taken in 171 relatives of HSR+ patients. Variance component analysis suggested that genetic differences may explain 61% of the phenotypic variability of plasma APP activity (P<0.001) and the kinetic parameters that characterized kinin degradation. We also showed that the C-2399A single-nucleotide polymorphism at the XPNPEP2 locus was a significant predictor of APP activity in the 39 HSR- controls (P=0.029). Furthermore, a recessive genetic model for the A allele disclosed a significant difference in mean APP activity by genotype (P<0.001). Finally, our study defined the nonspecific inhibition of recombinant APP by some ACEis. I…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In hypertensive patients who experienced ACEi-angioedema, impaired degradation of bradykinin and des-Arg 9 -bradykinin has been associated with a decreased activity of plasma APP [Adam et al., 2002;Blais et al., 1999;Molinaro et al., 2006].”
From A functional XPNPEP2 promoter haplotype leads to reduced plasma aminopeptidase P and increased risk of ACE inhibitor‐induced angioedema (2011) · cites this paper as Molinaro et al., 2006
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Applied Linear Statistical Models
Ziegel, E. R., Neter, J., Wasserman, W., & Kutner, M. (1992) · Technometrics · doi:10.2307/1269588 · Cited by 9,907
Applied Linear Statistical Models
(1997) · Technometrics · doi:10.1080/00401706.1997.10485141 · Cited by 7,185
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394
Mathematical Statistics and Data Analysis
Rabinowitz, L. (1989) · Technometrics · doi:10.1080/00401706.1989.10488573 · Cited by 3,116
Multipoint Quantitative-Trait Linkage Analysis in General Pedigrees
Almasy, L., & Blangero, J. (1998) · The American Journal of Human Genetics · doi:10.1086/301844 · Cited by 3,028
Bioregulation of kinins: kallikreins, kininogens, and kininases.
Bhoola, K. D., Figueroa, C. D., & Worthy, K. (1992) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00058-4 · Cited by 1,744 · cited 1×
“It is subsequently metabolized, mainly by three zinc metallopeptidases.(11,12) ACE and XPro-aminopeptidase (aminopeptidase P (APP)) are the first and second inactivating metallopeptidases of BK, respectively.”
BackgroundAngiotensin-Converting Enzyme Inhibitors
Brown, N. J., & Vaughan, D. E. (1998) · Circulation · doi:10.1161/01.cir.97.14.1411 · Cited by 958
Leeb-Lundberg, L. M. F., Marceau, F., Müller-Esterl, W., Pettibone, D. J., & Zuraw, B. L. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.1.2 · Cited by 943
Mathematical Statistics and Data Analysis
Ziegel, E. R., & Rice, J. (1995) · Technometrics · doi:10.2307/1269179 · Cited by 842
Marceau, F., Hess, J. F., & Bachvarov, D. R. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01371-1 · Cited by 602 · cited 1×
“BK exerts its pharmacological activities through its constitutively expressed kinin B2 receptor, 13 although des-Arg(9)-BK binds to the B1 receptor, the synthesis of which is increased by different cytokines.(14) Both B1 and B2 receptor agonists have several physiological activities(13) including the ability to dilate…”
BackgroundThe Kallikrein-Kinin System: Current and Future Pharmacological Targets
Moreau, M. E., Garbacki, N., Molinaro, G., Brown, N. J., Marceau, F., & Adam, A. (2005) · Journal of Pharmacological Sciences · doi:10.1254/jphs.srj05001x · Cited by 457 · cited 1×
“These results could also help us to understand the regulation of B1 receptor expression in dialyzed patients and could objectivate the usefulness of non-peptidic B1 antagonists, now in clinical development, for the treatment of metallopeptidase inhibitor side effects.(32,33)”
BackgroundSelf-citationAngiotensin-converting enzyme is a GPI-anchored protein releasing factor crucial for fertilization
Kondoh, G., Tojo, H., Nakatani, Y., Komazawa, N., Murata, C., Yamagata, K., Maeda, Y., Kinoshita, T., Okabe, M., Taguchi, R., et al. (2005) · Nature Medicine · doi:10.1038/nm1179 · Cited by 208 · cited 1×
“More interesting, however, is the recent report that ACE has glycosylphosphatidylinositolase activity.(31) As both APP and ACE are often expressed in the same cells, it will be interesting to see whether ACE levels affect membrane-bound APP.”
BackgroundSingle-tube genotyping without oligonucleotide probes
Germer, S., & Higuchi, R. (1999) · Genome Research · doi:10.1101/gr.9.1.72 · Cited by 199 · cited 1×
“Genotyping of C-2399A SNP, described elsewhere,(21) required the modification of an allele-specific polymerase chain reaction assay.(39) The SNP genotypes served two purposes: (1) to compare allele and genotype frequencies between HSRþ and HSR patients; (2) to evaluate associations between SNP genotypes and phenotypes…”
MethodAminopeptidase P in individuals with a history of angio-oedema on ACE inhibitors
Adam, A., Cugno, M., Molinaro, G., Perez, M., Lepage, Y., & Agostoni, A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08914-6 · Cited by 181
Self-citationHemodialysis Membranes: Interleukins, Biocompatibility, and Middle Molecules
Diaeresisrl, W. H. H. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v13suppl_1s62 · Cited by 168
Bradykinin and des-Arg9-bradykinin metabolic pathways and kinetics of activation of human plasma
Cyr, M., Lepage, Y., Blais, C., Gervais, N., Cugno, M., Rouleau, J.-L., & Adam, A. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.281.1.h275 · Cited by 160
Self-citationBradykinin is a mediator of anaphylactoid reactions during hemodialysis with AN69 membranes
VERRESEN, L., Fink, E., Lemke, H., & Vanrenterghem, Y. F. C. (1994) · Kidney International · doi:10.1038/ki.1994.195 · Cited by 141
Molinaro, G., Cugno, M., Perez, M., Lepage, Y., Gervais, N., Agostoni, A., & Adam, A. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.038067 · Cited by 137
Self-citationDuan, Q. L., Nikpoor, B., Dubé, M.-P., Molinaro, G., Meijer, I. A., Dion, P., Rochefort, D., Saint-Onge, J., Flury, L., Brown, N. J., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/496899 · Cited by 126 · cited 5×
“In addition, we observed a deletion of 175 bp in one case of AE.”
BackgroundResultInfluentialSelf-citationAngiotensin-converting-enzyme inhibitors and anaphylactoid reactions to high-flux membrane dialysis
VERRESEN, L., Waer, M., Vanrenterghem, Y. F. C., & Michielsen, P. P. (1990) · The Lancet · doi:10.1016/0140-6736(90)92904-v · Cited by 114
Bradykinin generation by dialysis membranes: possible role in anaphylactic reaction.
Schulman, G., Hakim, R., Arias, R., Silverberg, M., Kaplan, A. P., & Arbeit, L. (1993) · Journal of the American Society of Nephrology · doi:10.1681/asn.v391563 · Cited by 87
Blais, C., Rouleau, J.-L., Brown, N. J., Lepage, Y., Spence, D., Munoz, C., Friborg, J., Geadah, D., Gervais, N., & Adam, A. (1999) · Immunopharmacology · doi:10.1016/s0162-3109(99)00133-2 · Cited by 78
Self-citationDécarie, A., Drapeau, G., Closset, J., Couture, R., & Adam, A. A. (1994) · Peptides · doi:10.1016/0196-9781(94)90214-3 · Cited by 67
Self-citationRaymond, P., Drapeau, G., Raut, R., Audet, R., Marceau, F., Ong, H., & Adam, A. A. (1995) · Journal of Immunological Methods · doi:10.1016/0022-1759(94)00320-v · Cited by 62
Self-citationInhibition by converting enzyme inhibitors of pig kidney aminopeptidase P.
Hooper, N. M., Hryszko, J., Oppong, S. Y., & Turner, A. J. (1992) · Hypertension · doi:10.1161/01.hyp.19.3.281 · Cited by 62 · cited 2×
“As early as 1992, Hooper et al.(30) reported that several ACEi inhibit APP purified from the pig kidney.”
BackgroundAminopeptidase P isozyme expression in human tissues and peripheral blood mononuclear cell fractions
Erşahin, Ç. H., Szpaderska, A. M., Orawski, A. T., & Simmons, W. H. (2005) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.12.023 · Cited by 61 · cited 2×
“hmAPP is mainly localized on the external site of the plasma membrane of endothelial cells, on the brush border membrane of epithelial cells in the intestine, and in renal proximal tubules.(15) hmAPP 200”
BackgroundResultBlais, C., Marc–Aurèle, J., Simmons, W. H., Loute, G., Thibault, P., Skidgel, R. A., & Adam, A. (1999) · Peptides · doi:10.1016/s0196-9781(99)00020-0 · Cited by 60
Self-citationSundaram, S., Cendoroglo, M., Cooker, L. A., Jaber, B. L., Faict, D., Holmes, C. J., & Pereira, B. J. G. (1997) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(97)90493-5 · Cited by 55
Kim, K.-S., Kumar, S., Simmons, W. H., & Brown, N. J. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35290-5 · Cited by 45 · cited 8×
“However, the APP inhibitor acts synergistically with quinapril to augment the wheal response to exogenous BK.28 In this study, we measured APP activity in the plasma of HSR , HSRþ , and their relatives.”
BackgroundInfluentialRole of Bradykinin in Anaphylactoid Reactions during Hemodialysis with AN69 Dialyzers
Schaefer, R. M., Fink, E., Schaefer, L., Barkhausen, R., Kulzer, P., & Heidland, A. (1993) · American Journal of Nephrology · doi:10.1159/000168666 · Cited by 45
Blais, C., Fortin, D., Rouleau, J. L., Molinaro, G., & Adam, A. A. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38947-5 · Cited by 41 · cited 1×
“has also been found in human heart preparations where it contributes to BK metabolism.(26) It has been hypothesized that hmAPP on endothelial cells inactivates BK and locally produced des-Arg(9)-BK.”
BackgroundSelf-citationMoreau, M. E., Dubreuil, P., Molinaro, G., Chagnon, M., Müller‐Esterl, W., Lepage, Y., Marceau, F., & Adam, A. A. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.088005 · Cited by 37 · cited 1×
“These results could also help us to understand the regulation of B1 receptor expression in dialyzed patients and could objectivate the usefulness of non-peptidic B1 antagonists, now in clinical development, for the treatment of metallopeptidase inhibitor side effects.(32,33)”
BackgroundSelf-citationMOLINARO, G., CARMONA, A. K., JULIANO, M. A., JULIANO, L., MALITSKAYA, E., YESSINE, M.-A., CHAGNON, M., LEPAGE, Y., SIMMONS, W. H., BOILEAU, G., et al. (2005) · Biochemical Journal · doi:10.1042/bj20040849 · Cited by 36 · cited 7×
“This substrate, which mimics the NH2-terminal sequence of the physiological substrate BK/ des-Arg(9)-BK, is highly specific for APP activity.(22) With plasma samples obtained from the reference population,(12) we demonstrated that APP activity measured according this new analytical approach, was not only correlated wi…”
BackgroundMethodResultInfluentialSelf-citationAnaphylactoid reactions during hemodialysis.
Schaefer, R. M., Schaefer, L., & Hörl, W. H. (1994) · PubMed · Cited by 36
Effects of aminopeptidase P inhibition on kinin-mediated vasodepressor responses
Kitamura, S.-I., Carbini, L. A., Simmons, W. H., & Scicli, A. G. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.276.5.h1664 · Cited by 34 · cited 1×
“In fact, inhibition of APP in rats synergizes the hypotensive action of injected BK, but this hypotension-potentiating influence is mostly seen in the presence of lisinopril.(27) In humans, apstatin has no effect on the inflammatory reaction induced by local subcutaneous BK injection in the forearm.”
BackgroundMolinaro, G. A., Adam, A. A., Lepage, Y., Hammerschmidt, D. E., Koenigbauer, U. F., & Eastlund, T. (2002) · Transfusion · doi:10.1046/j.1537-2995.2002.00196.x · Cited by 26 · cited 1×
“When ACE was inhibited, the low APP activity was associated with an increased half-life of exogenously added(16) or endogenously generated des-Arg(9)-BK.(19,20) We reported recently(21) that genetic factors partially regulated the activity of APP in eight families, each with one member who developed ACEi-associated an…”
BackgroundSelf-citationMarked dilutional acidosis complicating management of right ventricular myocardial infarction
Jaber, B. L., & Madias, N. E. (1997) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(97)90317-6 · Cited by 26
Rao, M., Jaber, B. L., & Balakrishnan, V. S. (2005) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2005.18316.x · Cited by 15
Kinin generation by hemodialysis membranes as a possible cause of anaphylactoid reactions.
Fink, E., Lemke, H., VERRESEN, L., & Shimamoto, K. (1994) · PubMed · Cited by 10
Preliminary survey of the occurrence of anaphylactoid reactions during haemodialysis
Bright, R., Torrence, M. E., Daley, W., & McClellan, W. (1999) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/14.3.799 · Cited by 7 · cited 2×
“The presence of HSR was defined on the basis of clinical criteria proposed recently by Bright et al.35 in a survey of HSR ‘as an incident involving two or more of the following symptoms occurring within 5–20 min of starting dialysis: abdominal cramps, nausea, vomiting or diarrhea; shortness of breath, chest tightness,…”
Method[Immune deficits in hemodialysis patients].
Jp, R. (1990) · PubMed · Cited by 3
Cited by
Cilia La Corte, A. L., Carter, A. M., Rice, G. I., Duan, Q. L., Rouleau, G. A., Adam, A., Grant, P. J., & Hooper, N. M. (2011) · Human Mutation · doi:10.1002/humu.21579 · Cited by 154
“In hypertensive patients who experienced ACEi-angioedema, impaired degradation of bradykinin and des-Arg9-bradykinin has been associated with a decreased activity of plasma APP [Adam et al., 2002; Blais et al., 1999; Molinaro et al., 2006].”
BackgroundSelf-citationA hypothesized role for dysregulated bradykinin signaling in COVID‐19 respiratory complications
Roche, J. A., & Roche, R. (2020) · The FASEB Journal · doi:10.1096/fj.202000967 · Cited by 127
Practical guidance for dialyzing a hemodialysis patient following acute brain injury
Davenport, A. (2008) · Hemodialysis International · doi:10.1111/j.1542-4758.2008.00271.x · Cited by 69
Factor XII mutations, estrogen-dependent inherited angioedema, and related conditions
Binkley, K. E. (2010) · Allergy Asthma and Clinical Immunology · doi:10.1186/1710-1492-6-16 · Cited by 61
Duan, Q., Binkley, K. E., & Rouleau, G. A. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.12.010 · Cited by 61
“This allele has been associated with decreased APP activity, decreased bradykinin and des-Arg9-BK degradation, and angioedema induced by ACE inhibitors.(20,21) Ten other blood relatives within this family also carry this polymorphism but are unaffected, including the female of undetermined phenotype (IV:6) with the Th…”
BackgroundSelf-citation
Metadata
- Authors
- Molinaro, G., Duan, Q. L., Chagnon, M., Moreau, M. E., Simon, P., Clavel, P., Lavaud, S., Boileau, G., Rouleau, G. A., Lepage, Y., Adam, A., & Chanard, J.
- Affiliations
- Université de Montréal (CA)
- Hôpital Notre-Dame (CA)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Chanard, J.
- Venue
- Kidney International
- Publisher
- Elsevier BV
- Published
- 2006-11
- Volume
- 70
- Issue
- 10
- Pages
- 1823-1831
- ISSN
- 0085-2538 (ISSN-L)
- OpenAlex
- W2010588890
- Cited by
- 29
- References
- 43
- Citations by year
- 2021: 1 · 2020: 2 · 2019: 1 · 2017: 1 · 2016: 1 · 2015: 2 · 2013: 2 · 2012: 1
- FWCI
- 1.88
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 3323 d)
- Locations
- Kidney International (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL079184)
- Topics
- Health Sciences › Medicine › Hematology › Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Keywords
- ACE inhibitors, aminopeptidase P, bradykinin degradation, AN69 membrane, genetic susceptibility, angioedema, adverse drug reactions
- MeSH terms
- Adult, Aged, Aminopeptidases, Angiotensin-Converting Enzyme Inhibitors, Bradykinin, Drug Hypersensitivity, Female, Renal Dialysis, Humans, Kinins, Genetic Linkage, Male, Middle Aged, Pedigree, Cohort Studies, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.